Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR) announced today that its drug candidate, rezpegaldesleukin, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ...

Much like the Title IX fact sheet issued by the DOE, this statement of interest is not law. While the DOJ raises compelling ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

Quince also offers a yearlong trial to decide if you ... the Sijo AiryWeight Eucalyptus Sheet Set is refreshingly soft and strikes the right balance of comfort, coolness, durability, and price.

ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2024. The report is available as an attachment and ...

Magnesium may help relieve or prevent period cramps. Learn the facts about magnesium, how much and what type to take, and its ...

Parex Resources expanded its joint venture with Ecopetrol. Learn more about PARXF stock here and why it is rated as Strong ...

Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...

Arrest Illegal If Reasons Not Informed; When Article 22 (1) Is Violated, Court Must Grant Bail Despite Statutory Restrictions: SC ...